March 1, 2022
NOT-CA-22-033 - Request for Information (RFI): Seeking Input from Multi-Cancer Early Detection Test Developers on Readiness for Participation in an NCI-Sponsored Clinical Utility Randomized Controlled Screening Trial
National Cancer Institute (NCI)
This Notice extends the response date for NOT-CA-22-033 "Request for Information (RFI): Seeking Input from Multi-Cancer Early Detection Test Developers on Readiness for Participation in an NCI-Sponsored Clinical Utility Randomized Controlled Screening Trial " to March 21, 2022.
The following sections of the NOT-CA-22-033 have been modified.
Key Dates
Currently reads:
Response Date: March 01, 2022
Modified to read (changes are shown below in bold italics):
Response Date: March 21, 2022
How to Submit a Response
Currently reads (first two lines):
Responses to this RFI must be submitted electronically to NCIMCED@nih.gov
Responses will be accepted through March 01, 2022.
Modified to read (changes are shown below in bold italics):
Responses to this RFI must be submitted electronically to NCIMCED@nih.gov
Responses will be accepted through March 21, 2022.
All other aspects of the RFI remain the same.
Christos Patriotis, Ph.D.,
National Cancer Institute (NCI)
Telephone: 240-276-7134
Email: patriotisc@mail.nih.gov